Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure

Pope, 1994, Current concepts: acid-reflux disorders, N Engl J Med, 331, 656, 10.1056/NEJM199409083311007 Spechler, 1996, The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett, Gastroenterology, 110, 614, 10.1053/gast.1996.v110.agast960614 Spechler, 1996, Barrett's esophagus, Semin Gastrointest Dis, 7, 51 Reid, 1992, Flow cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort, Gastroenterology, 102, 1212, 10.1016/0016-5085(92)90758-Q Reid, 1991, Barrett's esophagus and esophageal adenocarcinoma, Gastroenterol Clin North Am, 20, 817, 10.1016/S0889-8553(21)00590-2 Fitzgerald, 1998, Recent developments in the molecular characterization of Barrett's esophagus, Dig Dis, 16, 63, 10.1159/000016850 Smith, 1992, Prostanoid biosynthesis and mechanisms of action, Am J Physiol, 263, F181 Eberhart, 1995, Eicosanoids and the gastrointestinal tract, Gastroenterology, 109, 285, 10.1016/0016-5085(95)90296-1 DuBois, 1998, Cyclooxygenase in biology and disease, FASEB J, 12, 1063, 10.1096/fasebj.12.12.1063 Kujubu, 1991, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J Biol Chem, 266, 12866, 10.1016/S0021-9258(18)98774-0 Pritchard, 1994, Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo, J Biol Chem, 269, 8504, 10.1016/S0021-9258(17)37223-X Seibert, 1994, Pharmacological and biochemical demonstration of the role of cyclooxygenase-2 in inflammation and pain, Proc Natl Acad Sci USA, 91, 12013, 10.1073/pnas.91.25.12013 Fu, 1996, Inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX-2) expression in ulcerative colitis and Crohn's disease, Gastroenterology, 110, A910 Wong, 1997, Expression of inducible nitric oxide synthase and cyclooxygenase-2 and modulation by omeprazole in Helicobacter pylori gastritis (abstr), Gastroenterology, 112, A3321 Plummer, 1995, Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase, Carcinogenesis, 16, 1023, 10.1093/carcin/16.5.1023 Boolbol, 1996, Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis, Cancer Res, 56, 2556 Eberhart, 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1 Soydan, 1997, Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumors, Eur J Cancer, 33, 1508, 10.1016/S0959-8049(97)00168-8 Wilson, 1998, Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas, Cancer Res, 58, 2929 Oshima, 1996, Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell, 87, 803, 10.1016/S0092-8674(00)81988-1 Triadafilopoulos, 1996, Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus, Am J Gastroenterol, 91, 65 Paull, 1976, The histologic spectrum of Barrett's esophagus, N Engl J Med, 295, 476, 10.1056/NEJM197608262950904 McCardle, 1992, Distribution of dysplasia and early invasive carcinoma in Barrett's esophagus, Hum Pathol, 23, 479, 10.1016/0046-8177(92)90123-K Townbin, 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications, Proc Natl Acad Sci USA, 76, 4350, 10.1073/pnas.76.9.4350 Davidson, 1992, Blood group–related antigen expression in normal and metaplastic human upper gastrointestinal mucosa, Gastroenterology, 103, 1552, 10.1016/0016-5085(92)91177-6 Trier, 1980, Organ culture of the mucosa of human small intestine, Methods Cell Biol, 18, 365, 10.1016/S0091-679X(08)60693-7 Champion, 1994, Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus, Gastroenterology, 107, 747, 10.1016/0016-5085(94)90123-6 Kumble, 1996, Multifocal heterogeneity in villin and Ep-CAM expression in Barrett's esophagus, Int J Cancer, 66, 48, 10.1002/(SICI)1097-0215(19960328)66:1<48::AID-IJC9>3.0.CO;2-Z Smith, 1996, Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2, J Biol Chem, 271, 33157, 10.1074/jbc.271.17.9906 Fitzgerald, 1996, Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model, J Clin Invest, 98, 2120, 10.1172/JCI119018 Bennett, 1976, Prostaglandins and the alimentary tract, 247 Hawkey, 1985, Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease or treatment?, Gastroenterology, 89, 1162, 10.1016/0016-5085(85)90225-2 Tsujii, 1997, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential, Proc Natl Acad Sci USA, 94, 3336, 10.1073/pnas.94.7.3336 Kargman, 1996, Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts, Gastroenterology, 111, 445, 10.1053/gast.1996.v111.pm8690211 Mitchell, 1995, Cyclooxygenase-2: regulation and relevance to inflammation, Biochem Pharmacol, 50, 1535, 10.1016/0006-2952(95)00212-X Vane, 1995, New insights into the mode of action of anti-inflammatory drugs, Inflamm Res, 44, 1, 10.1007/BF01630479 Zhang, 1998, Dihydroxy bile acids activate the transcription of cyclooxygenase-2, J Biol Chem, 273, 2424, 10.1074/jbc.273.4.2424 Fitzgerald, 1998, Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus, Am J Physiol, 275, G47 Kaur, 1998, Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion, Gastroenterology, 118, A170, 10.1016/S0016-5085(98)80691-4 Jacoby, 1996, Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam, Cancer Res, 56, 710 Ristimaki, 1997, Expression of cyclooxygenase-2 in human gastric carcinoma, Cancer Res, 57, 1276 Kutchera, 1996, Prostaglandin synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect, Proc Natl Acad Sci USA, 93, 4816, 10.1073/pnas.93.10.4816 Hara, 1997, Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines, Jpn J Cancer Res, 88, 600, 10.1111/j.1349-7006.1997.tb00424.x Futaki, 1994, NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro, Prostaglandins, 47, 55, 10.1016/0090-6980(94)90074-4 Anderson, 1996, Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis, J Clin Invest, 97, 2672, 10.1172/JCI118717 Shiff, 1997, Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions, Gastroenterology, 13, 1992, 10.1016/S0016-5085(97)99999-6 DuBois, 1996, Cyclooxygenase, NSAIDs and colorectal cancer, J Gastroenterol, 31, 898, 10.1007/BF02358623